Literature DB >> 29217297

Defects in Bioenergetic Coupling in Schizophrenia.

Courtney R Sullivan1, Sinead M O'Donovan1, Robert E McCullumsmith2, Amy Ramsey3.   

Abstract

Synaptic neurotransmission relies on maintenance of the synapse and meeting the energy demands of neurons. Defects in excitatory and inhibitory synapses have been implicated in schizophrenia, likely contributing to positive and negative symptoms as well as impaired cognition. Recently, accumulating evidence has suggested that bioenergetic systems, important in both synaptic function and cognition, are abnormal in psychiatric illnesses such as schizophrenia. Animal models of synaptic dysfunction demonstrated endophenotypes of schizophrenia as well as bioenergetic abnormalities. We report findings on the bioenergetic interplay of astrocytes and neurons and discuss how dysregulation of these pathways may contribute to the pathogenesis of schizophrenia, highlighting metabolic systems as important therapeutic targets.
Copyright © 2017 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioenergetic coupling; Glucose utilization; Lactate shuttle; Metabolism; Mitochondria; Schizophrenia

Mesh:

Year:  2017        PMID: 29217297      PMCID: PMC5891385          DOI: 10.1016/j.biopsych.2017.10.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  127 in total

1.  Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.

Authors:  I Maurer; S Zierz; H Möller
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

Authors:  Frank A Middleton; Karoly Mirnics; Joseph N Pierri; David A Lewis; Pat Levitt
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 3.  Ubiquitin and the synapse.

Authors:  Ashok N Hegde; Aaron DiAntonio
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

Review 4.  Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders.

Authors:  Julie Pongrac; Frank A Middleton; David A Lewis; Pat Levitt; Károly Mirnics
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

5.  Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.

Authors:  T B Halene; R S Ehrlichman; Y Liang; E P Christian; G J Jonak; T L Gur; J A Blendy; H C Dow; E S Brodkin; F Schneider; R C Gur; S J Siegel
Journal:  Genes Brain Behav       Date:  2009-05-08       Impact factor: 3.449

Review 6.  Mitochondria, synaptic plasticity, and schizophrenia.

Authors:  Dorit Ben-Shachar; Daphna Laifenfeld
Journal:  Int Rev Neurobiol       Date:  2004       Impact factor: 3.230

7.  In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy.

Authors:  Fei Du; Alissa J Cooper; Thida Thida; Selma Sehovic; Scott E Lukas; Bruce M Cohen; Xiaoliang Zhang; Dost Ongür
Journal:  JAMA Psychiatry       Date:  2014-01       Impact factor: 21.596

8.  Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.

Authors:  Dan Shan; Elizabeth K Lucas; Jana B Drummond; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2013-01-26       Impact factor: 4.939

9.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.

Authors:  L Pellerin; P J Magistretti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.

Authors:  G Kirov; A J Pocklington; P Holmans; D Ivanov; M Ikeda; D Ruderfer; J Moran; K Chambert; D Toncheva; L Georgieva; D Grozeva; M Fjodorova; R Wollerton; E Rees; I Nikolov; L N van de Lagemaat; A Bayés; E Fernandez; P I Olason; Y Böttcher; N H Komiyama; M O Collins; J Choudhary; K Stefansson; H Stefansson; S G N Grant; S Purcell; P Sklar; M C O'Donovan; M J Owen
Journal:  Mol Psychiatry       Date:  2011-11-15       Impact factor: 15.992

View more
  15 in total

1.  Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia.

Authors:  Eduard Bentea; Erica A K Depasquale; Sinead M O'Donovan; Courtney R Sullivan; Micah Simmons; James H Meador-Woodruff; Ying Zhou; Chongchong Xu; Bing Bai; Junmin Peng; Hongjun Song; Guo-Li Ming; Jarek Meller; Zhexing Wen; Robert E McCullumsmith
Journal:  Mol Omics       Date:  2019-06-10

2.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

3.  Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia.

Authors:  Cassidy L Moody; Adam J Funk; Emily Devine; Ryan C Devore Homan; Detlev Boison; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

Review 4.  Astrocyte Bioenergetics and Major Psychiatric Disorders.

Authors:  Ivan V Maly; Michael J Morales; Mikhail V Pletnikov
Journal:  Adv Neurobiol       Date:  2021

Review 5.  Schizophrenia: a disorder of broken brain bioenergetics.

Authors:  Nicholas D Henkel; Xiajoun Wu; Sinead M O'Donovan; Emily A Devine; Jessica M Jiron; Laura M Rowland; Zoltan Sarnyai; Amy J Ramsey; Zhexing Wen; Margaret K Hahn; Robert E McCullumsmith
Journal:  Mol Psychiatry       Date:  2022-03-09       Impact factor: 13.437

6.  Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia.

Authors:  Sinead M O'Donovan; Ana Franco-Villanueva; Valentina Ghisays; Jody L Caldwell; Vahraim Haroutunian; Lisa M Privette Vinnedge; Robert E McCullumsmith; Matia B Solomon
Journal:  Schizophr Res       Date:  2018-07-13       Impact factor: 4.939

7.  Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder.

Authors:  Jill R Glausier; John F Enwright; David A Lewis
Journal:  Am J Psychiatry       Date:  2020-10-29       Impact factor: 18.112

8.  Analysis of GWAS-Derived Schizophrenia Genes for Links to Ischemia-Hypoxia Response of the Brain.

Authors:  Rainald Schmidt-Kastner; Sinan Guloksuz; Thomas Kietzmann; Jim van Os; Bart P F Rutten
Journal:  Front Psychiatry       Date:  2020-05-12       Impact factor: 4.157

Review 9.  Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells.

Authors:  Ruhel Ahmad; Vincenza Sportelli; Michael Ziller; Dietmar Spengler; Anke Hoffmann
Journal:  Cells       Date:  2018-09-17       Impact factor: 6.600

Review 10.  Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.

Authors:  João M N Duarte; Lijing Xin
Journal:  Neurochem Res       Date:  2018-04-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.